Learn more

CTI BIOPHARMA CORP

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    151,834
  • Filing trend
    ⇩ 100.0%
About

CTI BIOPHARMA CORP has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD, CENTAURUS BIOPHARMA CO LTD and NEUROCRINE BIOSCIENCES INC.

Patent filings per year

Chart showing CTI BIOPHARMA CORPs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Lee Cheng Hsia Angeline 14
#2 William Anthony Deodaunia 14
#3 Sun Eric T 7
#4 Poulsen Anders 7
#5 Nagaraj Harish Kumar Mysore 7
#6 Dymock Brian 7
#7 Tan Yee Ling Evelyn 7
#8 Blanchard Stephanie 6
#9 Yu Xuezhong 4
#10 Betts Brian C 4

Latest patents

Publication Filing date Title
US2017112846A1 Oxygen linked pyrimidine derivatives
WO2017058950A1 Methods of treating transplant rejection
AU2009294311A1 Platinum complex with antitumor activity
TW201418263A Oxygen linked pyrimidine derivatives